Daiwa Securities Group
GBIO

Daiwa Securities Group’s Generation Bio GBIO Stock Holding History

Daiwa Securities Group’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19
Closed -$1K – 1346
2023
Q3 		$1K Hold
19
– – ﹤0.01% 1253
2023
Q2 		$1K Hold
19
– – ﹤0.01% 1274
2023
Q1 		$1K Hold
19
– – ﹤0.01% 1252
2022
Q4 		$1K Hold
19
– – ﹤0.01% 1269
2022
Q3 		$1K Hold
19
– – ﹤0.01% 1288
2022
Q2 		$1K Hold
19
– – ﹤0.01% 1289
2022
Q1 		$1K Hold
19
– – ﹤0.01% 1308
2021
Q4 		$1K Hold
19
– – ﹤0.01% 1335
2021
Q3 		$5K Buy
19
+8
+73% +$1.92K ﹤0.01% 1176
2021
Q2 		$3K Hold
11
– – ﹤0.01% 1108
2021
Q1 		$3K Buy
11
+2
+22% +$640 ﹤0.01% 1104
2020
Q4 		$2K Buy
+9
New +$2.89K ﹤0.01% 1121

Other funds holding GBIO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Daiwa Securities Group's GBIO Position: Q4 2023 in Review

Daiwa Securities Group sold out of Generation Bio (GBIO) in Q4 2023, closing a stake of 19 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in GBIO in Q4 2020 and held it in 12 quarters. The position peaked at $5K in Q3 2021. 74 funds tracked by Wall St. Rank hold GBIO as of Q4 2023.

  • Daiwa Securities Group reported no remaining Generation Bio position as of Q4 2023 after selling out during the quarter.
  • Daiwa Securities Group sold 19 Generation Bio shares in Q4 2023, an estimated $1K.
  • Daiwa Securities Group first reported a position in Generation Bio in Q4 2020 and held it in 12 quarters.
  • Daiwa Securities Group's Generation Bio position peaked at $5K in Q3 2021.
  • 74 funds tracked by Wall St. Rank held Generation Bio as of Q4 2023.

Based on Daiwa Securities Group's 13F filing for Q4 2023, filed 31 Jan 2024.